Top compounds associated with response to RP11-307N16.6


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 2e-05
mRNA PLX4720 CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA PD318088 CTRPv2 pan-cancer AAC 0.16 4e-05
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 9e-05
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 9e-05
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.21 0.0001
mRNA RO4929097 CTRPv2 pan-cancer AAC 0.22 0.0002
mRNA austocystin d CTRPv2 pan-cancer AAC 0.15 0.0002
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.14 0.0007
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0007
Download CSV